Prelude Therapeutics Inc (PRLD) Balance Sheet
As of 2026-06-30 (10-Q), Prelude Therapeutics Inc (PRLD) reported total assets of $189.4M, total liabilities of $55.6M and shareholders' equity of $133.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $26.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRLDPrelude Therapeutics IncFollow PRLD — free
—
Price chart with a free account
- Market cap
- 289.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 218.3 | 31.8 | 30.6 | 25.3 | 12.5 | 35.3 | 26.3 | |
| Short-term investments | — | 259.4 | 171.1 | 207.6 | 121.1 | 68.0 | 125.4 | |
| Current assets | 220.8 | 295.1 | 204.4 | 235.6 | 135.9 | 105.7 | 154.9 | |
| Total assets | 223.6 | 305.1 | 220.5 | 277.7 | 175.5 | 141.3 | 189.4 | |
| Current liabilities | 11.4 | 19.2 | 21.7 | 21.8 | 25.6 | 53.0 | 38.0 | |
| Total liabilities | 11.4 | 19.2 | 25.1 | 40.6 | 44.1 | 72.7 | 55.6 | |
| Shareholders' equity | 212.2 | 285.9 | 195.4 | 237.1 | 131.5 | 68.6 | 133.7 |
USD millions · SEC XBRL
Prelude Therapeutics Inc — questions
- How much cash does Prelude Therapeutics Inc have?
- $26.3M in cash and cash equivalents as of 2026-06-30.
- What are Prelude Therapeutics Inc's total assets?
- $189.4M as of 2026-06-30.
- What is Prelude Therapeutics Inc's shareholders' equity?
- $133.7M as of 2026-06-30.
Every figure on this page comes from Prelude Therapeutics Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.